Kandi Technologies Acquires Jiangxi Huiyi For $7.7M
Kandi Technologies Group Inc (NASDAQ:KNDI) has acquired cell producer Jiangxi Province Huiyi New Energy Co Ltd (Jiangxi Huiyi) for $7.7 million in cash.…
Kandi Acquires Jiangxi Huiyi For ~$7.7M In Cash
Kandi Technologies Group, Inc. (the "Company," "we" or "Kandi") (NASDAQ GS: KNDI), today announced the expansion of its battery cell business with the acquisition of a leading cell producer
Kandi Technologies Offers Retail Financing Options With Synchrony
Electric vehicle manufacturer Kandi Technologies Group Inc (NASDAQ:KNDI) has signed an agreement with Synchrony Financial (NYSE:SYF), a consumer financial services company, to provide retail…
Kandi America Announces Retail Financing Options
Kandi America, the U.S. subsidiary of Kandi Technologies Group Inc. (NASDAQ GS: KNDI), an international electric vehicle and powersports manufacturer, today announced it has entered into an agreement with Synchrony,
Kandi Technologies Shares Spike Higher Following Tweet From Co. ‘Kandi is Ready!’
https://twitter.com/kandiamerica/status/1408455039815933954
Electric Vehicle Stocks See Volume; No New Money For Electric Vehicle Rebates In Bipartisan Infrastructure Framework
-Reuters Citing White House Fact Sheet
11 Consumer Discretionary Stocks Moving In Wednesday’s After-Market Session
Gainers
BurgerFi International (NASDAQ:BFI) stock rose 3.1% to $10.63 during Wednesday's after-market session. BurgerFi International's trading volume hit 290 shares by close, accounting for 0.1% of its average volume over the last 100 days.
Kandi Technologies Group Insights: Return On Capital Employed
In Q1, Kandi Technologies Group (NASDAQ:KNDI) posted sales of $15.98 million. Earnings were up 334.04%, but Kandi Technologies Group still reported an overall loss of $22.85 million. In Q4, Kandi Technologies Group brought in $32.39 million in sales but lost $5.26 million in earnings.
24 Stocks Moving in Friday’s Pre-Market Session
Gainers
Senseonics Holdings, Inc. (NYSE: SENS) rose 37.1% to $2.81 in pre-market trading after the company disclosed results from a PROMISE study evaluating its Eversense CGM System for up to 180 days. The Eversense CGM is a continuous glucose monitoring device.